Atrium Hernia Mesh Lawsuits To Be Selected For First Trial in May 2020

The U.S. District Judge presiding over all federal Atrium C-Qur hernia mesh lawsuits has called for the parties to narrow down the list of potential bellwether cases to just two cases by the end of the month, which will be prepared for early trial dates later this year.

There are currently about 1,700 product liability lawsuits filed against Atrium Medical throughout the federal court system, each involving similar allegations that plaintiffs experienced problems with a hernia mesh system known as C-Qur (pronounced “secure”), which featured a unique design involving polypropylene patch with an an Omega-3 fatty acid (O3FA) gel coating.

While this design was intended to reduce scar tissue formation and promote fixation of the mesh to the abdominal wall, plaintiffs claim that the C-Qur patch actually increased the risk of an inflammatory response, bowel adhesions and other painful complications, often resulting in additional surgery.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More See If You Qualify For Compensation

Given similar questions of fact and law raised in the complaints brought throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for all Atrium C-Qur hernia mesh cases in December 2016, centralizing the cases before U.S. District Judge Landya McCafferty in New Hampshire, for coordinating discovery, pretrial rulings and a “bellwether” process, where a group of representative claims have been prepared for trial to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the cases.

In July, the parties selected eight cases for a bellwether trial pool, and the first case was scheduled to begin on May 20, 2020. In a case management order (PDF) issued on December 17, Judge McCafferty called on the parties to further narrow that pool down to just two cases, using a process the parties themselves have already agreed upon.

First, each party will be allowed to strike one case from previously selected pool of eight cases, leaving six. Then each side will select one of the remaining case by January 31, which will then be set for the first or second bellwether trial.

Judge McCafferty stipulated that the first case to go to trial should involve a single plaintiff, and parties should attempt to reach an agreement on what that first case will be, the manner of the trial and the timing of the second trial. They must submit a report to the court on those details by February 7. Failing an agreement between the parties, the court will make a selection and resolve any disagreements by February 28.

While the outcomes of these “bellwether” trials will not be binding on other claims, the process is designed to facilitate potential hernia mesh settlements that may be necessary to avoid the need for hundreds of individual trials in various U.S. District Courts nationwide following the coordinated MDL proceedings.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.